Abbott Medical Devices — Operating Earnings decreased by 4.3% to $1.89B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 17.7%, from $1.61B to $1.89B. Over 4 years (FY 2021 to FY 2025), Medical Devices — Operating Earnings shows an upward trend with a 12.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates improved profitability, better cost control, or higher sales volume.
Represents the profit generated by the medical devices segment after deducting operating expenses from net sales. It ser...
Standard operating profit metric used for segment reporting across all sectors.
abt_segment_medical_devices_operating_earnings| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.21B | $1.16B | $1.14B | $1.08B | $1.16B | $1.04B | $1.14B | $1.08B | $1.39B | $1.34B | $1.50B | $1.36B | $1.51B | $1.51B | $1.77B | $1.61B | $1.80B | $1.83B | $1.98B | $1.89B |
| QoQ Change | — | -4.0% | -1.8% | -5.4% | +7.1% | -10.0% | +9.4% | -5.2% | +28.5% | -3.1% | +11.8% | -9.4% | +10.8% | +0.4% | +17.2% | -9.2% | +11.6% | +1.8% | +8.1% | -4.3% |
| YoY Change | — | — | — | — | -4.4% | -10.4% | -0.2% | +0.0% | +19.9% | +29.2% | +32.0% | +26.2% | +8.8% | +12.7% | +18.1% | +18.3% | +19.2% | +20.9% | +11.6% | +17.7% |